These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 15274383

  • 1. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2004; 24(3b):1953-6. PubMed ID: 15274383
    [Abstract] [Full Text] [Related]

  • 2. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W.
    Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
    [Abstract] [Full Text] [Related]

  • 3. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Jun; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

  • 5. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 6. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H, Ishikawa S, Satoh H, Ishikawa H, Sakai M, Yamamoto T, Onizuka M, Sakakibara Y.
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
    [Abstract] [Full Text] [Related]

  • 7. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Oct; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, Barak V.
    Anticancer Res; 1999 Oct; 19(4C):3549-52. PubMed ID: 10629651
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer.
    Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T.
    Anticancer Res; 2010 Jul; 30(7):3099-102. PubMed ID: 20683062
    [Abstract] [Full Text] [Related]

  • 10. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M.
    Cancer; 2006 Dec 15; 107(12):2842-9. PubMed ID: 17103443
    [Abstract] [Full Text] [Related]

  • 11. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2006 Dec 15; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 12. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec 15; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S.
    Ann Thorac Surg; 2007 Jan 15; 83(1):216-21. PubMed ID: 17184666
    [Abstract] [Full Text] [Related]

  • 14. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.
    Anticancer Res; 2001 Jan 15; 21(4B):3085-92. PubMed ID: 11712815
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH, Song XR, Liu MQ, Zhang XQ, Zheng L, Li XJ, Liu PX.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 15; 26(6):345-8. PubMed ID: 15312344
    [Abstract] [Full Text] [Related]

  • 16. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb 15; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
    Ebert W, Hoppe M, Muley T, Drings P.
    Anticancer Res; 1997 Feb 15; 17(4B):2875-8. PubMed ID: 9329552
    [Abstract] [Full Text] [Related]

  • 18. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
    Vollmer RT, Govindan R, Graziano SL, Gamble G, Garst J, Kelley MJ, Christenson RH.
    Clin Cancer Res; 2003 May 15; 9(5):1728-33. PubMed ID: 12738727
    [Abstract] [Full Text] [Related]

  • 19. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
    Cedrés S, Nuñez I, Longo M, Martinez P, Checa E, Torrejón D, Felip E.
    Clin Lung Cancer; 2011 May 15; 12(3):172-9. PubMed ID: 21663860
    [Abstract] [Full Text] [Related]

  • 20. CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.
    Ebert W, Muley T.
    Anticancer Res; 1999 May 15; 19(4A):2669-72. PubMed ID: 10470217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.